人体削片市场－全球产业规模、份额、趋势、机会及预测（依技术、类型、应用、地区及竞争格局划分，2021-2031年）

全球人体微晶片市场预计将从 2025 年的 20.6 亿美元成长到 2031 年的 30.2 亿美元，复合年增长率为 6.58%。

此领域涉及将RFID或NFC电路皮下植入，作为门禁控制、金融交易和医疗资料储存的识别标识。推动这一领域成长的主要因素是对互通性日益增长的需求，这种互通性无需实体令牌，并且需要可靠的身份验证方法。相容通讯基础设施的广泛普及也进一步促进了这一扩张。例如，根据智慧支付协会（SPA）的数据，到2024年，全球出货的支付卡中将有92%是非接触式支付卡，显示嵌入式支付解决方案的技术基础已经成熟。

阻碍市场发展的主要挑战之一是公众对隐私和伦理界限日益严格的审查，这导致了立法方面的阻力。对监控和身体自主权完整性的担忧促使多个司法管辖区的监管机构先发制人地禁止在职场强制植入晶片。加之公众对潜在安全漏洞的担忧，这些监管障碍严重阻碍了大规模商业性应用，延缓了该技术从小众生物骇客群体向大众消费市场的过渡。

市场驱动因素

植入式技术在即时健康监测领域的拓展是推动市场发展的重要因素，它解决了外部配戴装置无法连续撷取医疗级生物特征资料的难题。皮下微晶片提供了一种永久性解决方案，可以追踪生命征象和神经活动，避免了可移除设备常见的依从性问题和电池续航限制。该领域已取得显着进展。 2024年8月，Neuralink公司宣布成功为第二位人体患者植入脑机接口，标誌着神经记录技术的商业性可行性取得了突破性进展。同时，远端监测的需求也在不断增长。 HealthArc于2024年10月发布的报告指出，到2024年，美国使用远端患者监护的患者人数将达到3000万人。

此外，对非接触式和无摩擦支付解决方案日益增长的需求是第二大驱动因素，推动了人们从实体钱包和智慧型手机转向生物识别整合支付方式。消费者越来越倾向于无需携带实体凭证即可进行交易，并且更喜欢使用微晶片进行金融交易和交通出行。这种行为变化为植入的普及创造了有利环境，因为用户已经习惯了「一触即付」的支付方式。根据 Marqeta 于 2024 年 7 月发布的《2024 年支付市场报告》，80% 的英国受访者表示在上週使用过某种形式的非接触式支付，这表明近距离场通讯 (NFC) 的市场渗透率很高，而微晶片市场正致力于利用这一趋势。

市场挑战

对隐私和伦理界限日益严格的审查给全球人体微晶片市场带来了巨大障碍。皮下植入意味着人体永久性改造，需要前所未有的消费者信任，而目前这种信任度严重不足。公众对身体自主权和非法监视可能性的担忧造成了严重的信任赤字，这种赤字远比反对标准穿戴式技术更难消除。这种公众的怀疑加剧了立法阻力，并导致监管机构实施严格的禁令，阻碍了供应商接触到规模化成长所需的庞大消费群。

这种阻力在更广泛的识别技术领域也同样存在，而信任的缺失正是限制技术阻碍因素。根据生物辨识研究所2024年的调查，58%的产业专家认为隐私和资料保护问题是生物识别和数位身分解决方案市场扩张的最大障碍。这种持续的怀疑态度阻碍了对必要读取基础设施的投资，并加剧了市场的碎片化。因此，这项技术仍然局限于小众群体，未能获得推动全球市场扩张所需的广泛商业性认可。

市场趋势

随着各组织机构迫切寻求降低传统密码系统漏洞的风险，使用微晶片作为硬体符记进行多因素数位身分验证的应用正以惊人的速度成长。网路钓鱼和凭证窃取攻击手段的日益复杂化，正推动安全通讯协定转向能够抵御网路钓鱼攻击的硬体身分验证方法。皮下植入式设备能够有效地实现这一目标。企业强制要求使用实体安全金钥进行访问，进一步推动了这一趋势，这与微晶片植入技术的功能有着直接的相似性，后者可以作为永久且不会遗失的代币。根据 Okta 于 2025 年 12 月发布的《2025 年安全登入趋势报告》，防网路钓鱼身分验证方法的采用率几乎同比增长了一倍，但仍有 93% 的员工用户依赖密码，这凸显了便捷的嵌入式令牌的巨大市场缺口。

同时，对无缝、现代化门禁系统的需求正在改变实体识别格局，企业园区采用微晶片进行门禁和安全管理已成为主流。各组织机构正逐步抛弃传统的塑胶徽章，转而建构整合的数位生态系统，透过单一身分识别码即可存取建筑物、工作站，甚至完成食堂支付。数位和实体门禁控制基础设施的整合降低了微晶片解决方案的普及门槛，与容易遗失的门禁卡相比，微晶片解决方案具有更高的便利性和安全性。这种需求也体现在关键产业企业的财务表现。根据ASSA ABLOY于2025年2月发布的2024年第四季报告，预计2024年电子机械门禁解决方案的销售额将成长8%，证实了企业对旨在取代人体微晶片的数位化门禁控制系统的强劲需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球人体削片市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依技术分类（RFID（无线射频辨识）、NFC（近距离场通讯）、其他）
  • 按类型（植入式微晶片、非植入式微晶片）
  • 按应用领域（医疗识别和监控、个人识别和门禁控制、金融交易等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美人体削片市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲人体削片市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区人体削片市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲人体削片市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲人体削片市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球人体削片市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• VeriChip Corporation
• Biohax International AB
• Dangerous Things LLC
• Three Square Market
• Kaspersky Lab
• McAfee Corp.
• Symantec Corporation
• ARM Holdings plc
• NXP Semiconductors NV
• Texas Instruments Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Human Microchipping Market is projected to expand from USD 2.06 Billion in 2025 to USD 3.02 Billion by 2031, registering a CAGR of 6.58%. This sector involves the subdermal implantation of RFID or NFC circuits that function as identifiers for access control, financial transactions, and medical data storage. A primary catalyst for this growth is the increasing demand for seamless, contactless interactions and high-assurance identity verification methods that eliminate the need for physical tokens. This expansion is further supported by the widespread availability of compatible communication infrastructure; for instance, the Smart Payment Association noted that 92% of payment cards shipped globally in 2024 were contactless-enabled, indicating that the technological foundation for implantable payment solutions is already well-established.

One significant challenge hindering market progression is the intensifying scrutiny regarding privacy and ethical boundaries, which has triggered legislative resistance. Concerns surrounding surveillance and the integrity of bodily autonomy have led regulators in various jurisdictions to implement preemptive bans on mandatory workplace microchipping. When combined with public anxiety about potential security vulnerabilities, these regulatory barriers create a substantial obstacle to mass commercial acceptance, slowing the technology's transition from niche biohacking communities to the general consumer market.

Market Driver

The expansion of implantable technology within real-time health monitoring acts as a major market accelerator, addressing the inability of external wearables to capture continuous, medical-grade biometric data. Subdermal microchips provide a permanent solution for tracking vital signs and neurological activity without the compliance issues or battery limitations associated with removable devices. Significant progress is evident in this area; Neuralink reported in August 2024 that it successfully implanted a brain-computer interface in a second human patient, marking a milestone for the commercial viability of neural recording. This aligns with rising demand for remote oversight, as highlighted by a HealthArc report from October 2024, which found that the number of patients utilizing remote patient monitoring in the United States rose to 30 million in 2024.

Additionally, the rising demand for contactless and frictionless payment solutions serves as a second major catalyst, driving the shift from physical wallets and smartphones toward bio-integrated payment credentials. Consumers are increasingly seeking transaction methods that remove the need to carry physical tokens, favoring the convenience offered by microchips for financial exchanges and transit access. This behavioral shift creates a fertile environment for implant adoption, as users are already habituated to tap-and-go infrastructures. According to Marqeta's "2024 State of Payments Report" from July 2024, 80% of UK respondents reported using a form of contactless payment in the previous week, illustrating the deep market penetration of near-field communication behaviors that the microchipping market aims to capitalize on.

Market Challenge

The intensifying scrutiny regarding privacy and ethical boundaries presents a critical obstruction to the Global Human Microchipping Market. Since subdermal implants represent a permanent modification to the human body, they require an unprecedented level of consumer confidence that is currently lacking. Apprehensions concerning bodily autonomy and the potential for unauthorized surveillance generate a profound trust deficit, which is far more difficult to resolve than objections to standard wearable technology. This public skepticism fuels legislative resistance, prompting regulators to enforce strict prohibitions that prevent vendors from accessing the broader consumer base required for scalable growth.

This resistance is quantifiable within the broader identity technology sector, where such trust deficits act as a primary restraint on adoption. According to the Biometrics Institute in 2024, 58% of industry professionals identified privacy and data protection concerns as the most significant barrier to market expansion for biometric and digital identity solutions. This prevailing skepticism deters investment in the necessary reading infrastructure and compels the market to remain fragmented. Consequently, the technology remains confined to niche communities, unable to secure the widespread commercial acceptance needed to drive global market momentum.

Market Trends

The utilization of microchips as hardware tokens for multi-factor digital authentication is gaining substantial traction as organizations urgently seek to mitigate the vulnerabilities of traditional password-based systems. With the rising sophistication of phishing and credential harvesting attacks, security protocols are pivoting toward unphishable, hardware-backed credentials that subdermal implants effectively provide. This trend is accelerating as enterprises mandate physical security keys for access, creating a direct functional parallel for microchip implants which act as permanent, unloseable tokens. According to Okta's "2025 Secure Sign-In Trends Report" from December 2025, the adoption of phishing-resistant authentication methods nearly doubled year-over-year, yet 93% of workforce users remained reliant on passwords, highlighting a critical market gap that convenient implantable tokens are positioned to fill.

Simultaneously, the adoption of microchips for corporate campus access and security is reshaping the physical identity landscape, driven by the need for seamless and modernized entry systems. Corporations are increasingly moving away from legacy plastic badges in favor of integrated digital ecosystems where a single identifier grants access to buildings, workstations, and cafeteria payments. This convergence of digital and physical access control infrastructure lowers the barrier to entry for microchipping solutions, which offer superior convenience and security compared to easily lost keycards. This demand is evident in the financial performance of key sector players; according to Assa Abloy's Q4 2024 report released in February 2025, sales of electromechanical access solutions grew by 8% in 2024, underscoring the robust enterprise appetite for the digitized entry mechanisms that human microchipping aims to supersede.

Key Market Players

• VeriChip Corporation
• Biohax International AB
• Dangerous Things LLC
• Three Square Market
• Kaspersky Lab
• McAfee Corp.
• Symantec Corporation
• ARM Holdings plc
• NXP Semiconductors N.V.
• Texas Instruments Inc.

Report Scope

In this report, the Global Human Microchipping Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Human Microchipping Market, By Technology

• RFID (Radio Frequency Identification)
• NFC (Near Field Communication)
• Others

Human Microchipping Market, By Type

• Implantable microchips
• Non-implantable microchips

Human Microchipping Market, By Application

• Medical identification and monitoring
• Personal identification and access control
• Financial transactions
• others

Human Microchipping Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Human Microchipping Market.

Available Customizations:

Global Human Microchipping Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Human Microchipping Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (RFID (Radio Frequency Identification), NFC (Near Field Communication), Others)
  • 5.2.2. By Type (Implantable microchips, Non-implantable microchips)
  • 5.2.3. By Application (Medical identification and monitoring, Personal identification and access control, Financial transactions, others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Human Microchipping Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Human Microchipping Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Human Microchipping Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Human Microchipping Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application

7. Europe Human Microchipping Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Human Microchipping Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
  • 7.3.2. France Human Microchipping Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Human Microchipping Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Human Microchipping Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Human Microchipping Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application

8. Asia Pacific Human Microchipping Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Human Microchipping Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
  • 8.3.2. India Human Microchipping Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Human Microchipping Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Human Microchipping Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Human Microchipping Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application

9. Middle East & Africa Human Microchipping Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Human Microchipping Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Human Microchipping Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Human Microchipping Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application

10. South America Human Microchipping Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Human Microchipping Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Human Microchipping Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Human Microchipping Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Human Microchipping Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. VeriChip Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Biohax International AB
• 15.3. Dangerous Things LLC
• 15.4. Three Square Market
• 15.5. Kaspersky Lab
• 15.6. McAfee Corp.
• 15.7. Symantec Corporation
• 15.8. ARM Holdings plc
• 15.9. NXP Semiconductors N.V.
• 15.10. Texas Instruments Inc.

16. Strategic Recommendations

17. About Us & Disclaimer